Increasing the efficiency of cancer chemotherapy with heparin: “Clinical study”

Abstract

Abstract Anticoagulation with heparin did not prevent tumor growth in man. Cancer chemotherapy became more effective when delivered to the patients after they became anticoagulated. Patients who had metastatic diseases and elevated plasma fibrinogen showed initial resistance to the anticoagulating effect of heparin.